연구성과로 돌아가기
2023 연구성과별 연구자 정보 (919 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Kim, Young-Chul | Kim, YC | 6 | Chonnam Natl Univ, Internal Med, Sch Med, Jeonnam, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Kim, Young-Chul | Kim, YC | 6 | Hwasun Hosp, Jeonnam, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Lee, Jeong Eun | Lee, JE | 7 | Chungnam Natl Univ Hosp, Internal Med, Daejeon, South Korea | R-8689-2019 | Lee, Jeong Eun | ||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Yoon, Sung Hoon | Yoon, SH | 8 | Pusan Natl Univ, Internal Med, Yangsan Hosp, Gyeongnam, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Choi, Chang Min | Choi, CM | 9 | Univ Ulsan, Asan Med Ctr, Internal Med, Coll Med, Seoul, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Lee, Jae Chul | Lee, JC | 10 | Univ Ulsan, Asan Med Ctr, Internal Med, Coll Med, Seoul, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Lee, Sung Yong | Lee, SY | 11 | Korea Univ, Internal Med, Guro Hosp, Seoul, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Lee, Shin Yup | Lee, SY | 12 | Kyungpook Natl Univ, Internal Med, Chilgok Hosp, Daegu, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Chun, Sung-Min | Chun, SM | 13 | Univ Ulsan, Asan Med Ctr, Pathol, Coll Med, Seoul, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Oh, In-Jae | Oh, IJ | 14 | Chonnam Natl Univ, Internal Med, Sch Med, Jeonnam, South Korea | ||||||
| Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial | Oh, In-Jae | Oh, IJ | 14 | Hwasun Hosp, Jeonnam, South Korea | ||||||
| Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial | Park, Cheol-Kyu | Park, CK | 1 | Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Gwangju 58128, South Korea | AAT-9872-2021 | Park, Cheol-Kyu | 0000-0001-8701-0786 | Park, Cheol Kyu | ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; | |
| Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial | Jun, Ha Ra | Jun, HR | 2 | Univ Ulsan, Asan Med Inst Convergence Sci & Technol, Asan Med Ctr,Coll Med, Dept Med Sci, Seoul 05505, South Korea | ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; | |||||
| Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial | Oh, Hyung-Joo | Oh, HJ | 3 | Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Gwangju 58128, South Korea | 0000-0002-9420-9096 | Oh, Hyung-joo | ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; | |||
| Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial | Lee, Ji-Young | Lee, JY | 4 | Univ Ulsan, Asan Med Inst Convergence Sci & Technol, Asan Med Ctr,Coll Med, Dept Med Sci, Seoul 05505, South Korea | ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; |
페이지 이동: